Ignite Creation Date:
2025-12-25 @ 12:11 AM
Ignite Modification Date:
2026-01-02 @ 1:37 PM
Study NCT ID:
NCT04156958
Status:
UNKNOWN
Last Update Posted:
2019-11-08
First Post:
2019-11-06
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Fruquintinib as Second-line Treatment for Advanced/Metastatic Biliary Tract Adenocarcinoma
Sponsor:
Sichuan University
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2019-12
Start Date Type:
ESTIMATED
Primary Completion Date:
2021-09
Primary Completion Date Type:
ESTIMATED
Completion Date:
2021-12
Completion Date Type:
ESTIMATED
First Submit Date:
2019-11-06
First Submit QC Date:
None
Study First Post Date:
2019-11-08
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-11-06
Last Update Post Date:
2019-11-08
Last Update Post Date Type:
ACTUAL